Imaging Memory T-Cells Stratifies Response to Adjuvant Metformin Combined with αPD-1 Therapy

The low response rates associated with immune checkpoint inhibitor (ICI) use has led to a surge in research investigating adjuvant combination strategies in an attempt to enhance efficacy. Repurposing existing drugs as adjuvants accelerates the pace of cancer immune therapy research; however, many c...

Descripción completa

Detalles Bibliográficos
Autores principales: Goggi, Julian L., Hartimath, Siddesh V., Khanapur, Shivashankar, Ramasamy, Boominathan, Chin, Zan Feng, Cheng, Peter, Chin, Hui Xian, Hwang, You Yi, Robins, Edward G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654631/
https://www.ncbi.nlm.nih.gov/pubmed/36361684
http://dx.doi.org/10.3390/ijms232112892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9654631/
https://www.ncbi.nlm.nih.gov/pubmed/36361684
http://dx.doi.org/10.3390/ijms232112892

Ejemplares similares